Investing in tomorrow's medicine

 

Mérieux Equity Partners is a global investment platform specialized in the healthcare & nutrition sector, working alongside entrepreneurs and companies with ambitious growth plan, offering them privileged access to sector-expertise and industrial network.

Launch video

News

SERB completes acquisition of BTG Specialty Pharmaceuticals

02/03/2021

This acquisition transforms the group into a global leader and a fully integrated specialty pharmaceutical platform.

Focus on Merieux Equity Partners' upcoming fifth investment vehicle - Mérieux Participations 4

08/03/2021

The Fund will be dedicated to Growth & Buyout, with a target of € 500M.
(article in Les Echos)

AcuSurgical raises €5.75 M in Series A financing, to advance its robotic ocular microsurgery platform

18/02/2021

The company will use the proceeds of the Series A financing to conduct clinical trials and reach regulatory approval with vitreo-retinal surgery as the first indication, paving the way for future applications that are not within the reach of surgeons today.

Key figures

43
Supported Companies
20
Team
>700
Assets Under Management
(€ million)
2
Offices (Lyon, Paris)